» Advanced search
Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 1-1 of 1 results.
 
{{ selectedCountPage }} items selected on this page, {{ selectedCountPage }} item selected on this page, {{ selectedCountTotal }} item in total {{ selectedCountTotal }} items in total
Study aim: Assessing the effects of wet cupping therapy on some inflammatory cytokines pre- and post-treatment such as hs-CRP\ IL-6 \ IL-1β \ TNF-α Assessing the hemological and biochemical modifications pre- and post-treatment on lipid profile and liver enzymes Design: A quasi-experimental trial study with self-controls on 20 patients Settings and conduct: This quasi-experimental trial study with self-controls is conducted on 20 study subjects selected in Omid Clinic in Hamadan- Iran according to our criteria inclusion through medical examinations by our experts in Iranian Medicine Participants/Inclusion and exclusion criteria: Men and women from 20- to 60-year-old affected by non alcoholic fatty liver disease grade II and III proved by ultrasonography of the liver, with or without alteration in their liver enzymes are included in the study. Patients who were affected by other chronic liver diseases or hepatitis and anemia; also heavy smokers, alcohol drinkers and patients with prolonged intake of drugs induced fatty liver diseases are excluded from the study. Intervention groups: Wet cupping therapy every 15 days for a total of three times on all patients Main outcome variables: Modifications on inflammatory cytokines such as hs-CRP / IL-1β / IL-6 / TNF-α
IRCTID: IRCT20220425054654N1
  1. Assessment of oleoylethanolamide supplementation on the expression of SIRT1, AMPK, PGC-1α, PPAR-γ, CEBP-α, CEBP- β, IL-6, and IL-10 genes, serum IL-6, IL-10, hs-CRP, IL-1β, TNF-α, TAC, GSH-Px, SOD, catalase, MDA, ox-LDL, and NRG-4 levels, and body composition in obese patients with non-alcoholic fatty liver disease (NAFLD)
  2. The effects of omega-3 fatty acids on oxaliplatin-induced neuropathy and inflammation in patients with colon cancer
  3. The clinical trial of evaluation of the effect of black cumin (nigella sativa) extract supplementation on serum levels of some inflammatory markers, liver enzymes, lipid profile ,insulin and fasting plasma glucose in patients with non-alcoholic fatty liver disease
  4. Investigating the therapeutic effect of wet cupping among patients with Non Alcoholic Fatty Liver Disease
  5. Assessment of pentoxifillin effects on the serum level of inflammatory cytokines(IL-6, IL-8, TNF-α) and liver transaminases in patient with non alcoholic steatohepatitis
  6. The effect of Camelina oil with and without Resistant dextrin supplementation on metabolic, inflammatory and anti-inflammatory markers in patients with Non-alcoholic fatty liver
  7. Gut Microbiome Composition and Response to Probiotic Intervention in Patients with Fibromyalgia using a Neurobiological Approach
  8. The effect of myo-inositol supplementation on nutritional status, cardiometabolic factors, liver function, oxidative stress, visfatin and hs-CRP levels, gene expression of insulin resistance pathway and HIF1α, NF-kB, TNF-α, Interleukin-1β and 6 in patients with non-alcoholic fatty liver disease.
  9. Study of the therapeutic role of plasmapheresis in patients with COVID-19 and its effect on serum levels of inflammatory factors
  10. The effect of time-restricted feeding (TRF) combined with a Lacto-Ovo-Vegetarian (LOV) diet on anthropometric indices, body composition, hepatic parameters, glucose homeostasis, lipid profile and inflammatory biomarkers in overweight and obese patients with non-alcoholic fatty liver disease: a Randomized Control Trial
Loading...